Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. Its etiology involves complex interactions among various biological, environmental, and social factors. The pathogen primarily spreads through airborne droplets, but whether it develops into active TB depends on the host’s immune status and external environmental influences. Genetic predisposition, lifestyle habits, and socioeconomic conditions can all increase the risk of disease onset after infection.
Pathologically, Mycobacterium tuberculosis has a unique cell wall structure that enables it to resist host immune responses and establish latent infections. Approximately one-fifth of the global population carries latent TB infection, but only a small proportion progress to active disease. This transformation is closely related to the immune system’s functionality, nutritional status, and exposure risk factors. Recent studies have also identified significant associations between specific genetic polymorphisms and susceptibility to TB.
Genetic factors play a crucial role in the pathogenesis of TB. Scientists have identified dozens of genetic regions associated with TB susceptibility in the human genome, with polymorphisms in the HLA gene family being particularly important for immune regulation. For example, certain HLA-DR alleles influence the activation efficiency of cytotoxic T lymphocytes, resulting in decreased ability to clear pathogens after infection.
Familial aggregation studies show that individuals with a family history of TB have a 2 to 3 times higher risk of developing the disease compared to the general population. This phenomenon reflects not only shared living environments that facilitate transmission but also similar genetic backgrounds. An international genetic study in 2018 indicated that specific variants in the TIRAP gene increase the likelihood of developing pulmonary TB by 40%. Additionally, polymorphisms in the CARD8 gene, related to inflammatory responses, have been confirmed to correlate positively with disease severity.
Environmental conditions are significant external factors influencing TB epidemiology. Densely populated living environments, such as refugee camps, shelters, or urban slums, with poor ventilation and enclosed spaces, facilitate pathogen transmission. WHO data show that when the concentration of Mycobacterium tuberculosis exceeds 100 organisms per cubic meter of air, the risk of infection for contacts increases by over 70%.
Regions with inadequate sanitation infrastructure, such as lack of clean drinking water and proper waste disposal systems, can indirectly weaken host immunity. Certain occupational groups, like miners and healthcare workers, who are exposed to dust or chemicals over long periods, may suffer respiratory barrier damage, increasing infection risk. Recent research also found that prolonged exposure to indoor air pollution (e.g., smoke from biomass fuel combustion) causes chronic lung inflammation, raising TB infection risk by 2.3 times.
Unhealthy lifestyle habits significantly impair immune function, becoming key factors in TB development. Smokers’ alveolar macrophage phagocytic function is reduced, and nicotine suppresses cytokine secretion, impairing initial defense against M. tuberculosis. WHO statistics show that daily smokers of 20 cigarettes have a 3.2 times higher risk of developing TB than non-smokers.
Malnutrition directly weakens the immune system’s ability to fight infections. Vitamin D deficiency suppresses antimicrobial peptide expression, and insufficient iron intake may promote bacterial growth. Alcoholics experience impaired liver detoxification, hindering immune cell activation, and acetaldehyde from alcohol metabolism damages respiratory mucosal barriers. Studies indicate that consuming more than 40g of alcohol daily increases TB risk by 65%.
Immunosuppression is a major driver of TB progression. HIV infection causes a dramatic decrease in CD4+ T cells, increasing latent infection relapse risk by 30 times. Patients on organ transplantation immunosuppressants have a TB incidence 5 to 10 times higher than the general population. Hyperglycemia in diabetics creates a conducive environment for M. tuberculosis growth, and insulin resistance can inhibit antimicrobial peptide gene expression.
Medical risks include long-term use of corticosteroids or biologics for autoimmune diseases, which increase infection risk by 2 to 4 times. Chronic kidney failure impairs leukocyte function, reducing bacterial clearance. Recent studies also show that prolonged exposure to secondhand smoke significantly lowers the expression of antimicrobial genes like LYZ and CCL5 in alveolar macrophages.
In summary, TB occurrence results from multiple interacting factors. Genetic susceptibility forms the baseline risk, environmental exposure determines infection likelihood, and immune/metabolic status influences disease progression. These three levels of risk factors work together to form a complete pathogenic chain from pathogen contact to clinical manifestation.
Public health strategies should target different levels of risk factors. Genetic screening can identify high-risk individuals; improving living conditions can block transmission; and lifestyle modifications such as smoking cessation and nutritional support can enhance host defenses. A comprehensive, multi-faceted approach is key to effectively controlling TB prevalence.
During treatment, maintain a balanced diet with adequate protein and vitamins to boost immunity. Avoid smoking, alcohol, and staying up late. Follow medical instructions to complete the full course of therapy without self-discontinuation. If side effects such as liver discomfort or skin rashes occur, report immediately to the healthcare team for adjustments.
Does BCG vaccination provide complete immunity against TB?The BCG vaccine reduces the risk of severe forms of TB (such as miliary TB), but its protective efficacy varies among individuals and is not 100%. Adults can still develop TB due to waning immunity or exposure to infection sources. Therefore, high-risk groups should undergo regular screening and take protective measures.
What other conditions should be considered in cases of chronic cough lasting over three weeks besides TB?Besides TB, chronic cough may be related to chronic obstructive pulmonary disease (COPD), asthma, lung cancer, or long-term exposure to air pollution. If accompanied by unexplained weight loss, hemoptysis, or fever, prompt chest X-ray and sputum culture tests are necessary to differentiate causes.
When can TB patients resume normal social activities?After 2 to 3 weeks of regular treatment, infectious patients usually no longer transmit bacteria. However, social activities can only resume gradually after the healthcare provider confirms sputum cultures are negative. Patients should wear medical masks and avoid close contact with immunocompromised individuals until completing therapy.
How should liver function abnormalities during TB treatment be managed?Some anti-TB drugs may elevate liver enzymes. Patients should have monthly liver function tests. If jaundice, sudden loss of appetite, or right upper quadrant pain occurs, medication should be stopped immediately, and a doctor consulted. The doctor will adjust medication types or doses based on liver function and recommend abstaining from alcohol during treatment.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
